Skip to main content
. Author manuscript; available in PMC: 2023 Dec 15.
Published in final edited form as: J Acquir Immune Defic Syndr. 2022 Dec 15;91(5):460–468. doi: 10.1097/QAI.0000000000003082

Table 2.

Participant characteristics by INH adherence at 3 and 6 months.

3 months (n=275) 6 months (n=264)
≥ 90% N (%) (n=189) < 90% N (%) (n=86) ≥ 90% N (%) (n=148) < 90% N (%) (n=116)
Alcohol use*, prior 3 months
None 79 (82.3) 17 (19.8) 73 (70.2) 31 (29.8)
Moderate 43 (72.9) 16 (27.1) 26 (61.9) 16 (38.1)
Unhealthy 67 (55.8) 53 (44.2) 49 (41.5) 69 (58.5)
Age (median [IQR]) 40 [35–49] 38 [32–44] 41 [35–49] 38 [32–44]
Gender
Female 102 (72.9) 38 (27.1) 83 (61.9) 51 (38.1)
Male 87 (64.4) 48 (35.6) 65 (50.0) 65 (50.0)
Depression
No 182 (68.7) 83 (31.3) 140 (56.7) 107 (43.3)
Yes 7 (70.0) 3 (30.0) 8 (47.1) 9 (52.9)
Grade 2+ LEEs or symptomsα
No 160 (70.2) 68 (29.8) 135 (58.2) 97 (41.8)
Yes 29 (61.7) 18 (38.3) 13 (40.6) 19 (59.4)
Low social support
No 126 (69.6) 55 (30.4) 97 (55.1) 79 (44.9)
Yes 63 (67.0) 31 (33.0) 51 (58.0) 37 (42.1)
ART adherence, prior 30 days
Good/fair/poor/very poor 13 (39.4) 20 (60.6) 15 (42.9) 20 (57.1)
Excellent/very good 176 (72.7) 66 (27.3) 133 (58.1) 96 (41.9)
More than a primary education
No 137 (68.5) 63 (31.5) 106 (55.2) 86 (44.8)
Yes 52 (69.3) 23 (30.7) 42 (58.3) 30 (41.7)
Married/cohabitating
No 57 (67.1) 28 (32.9) 48 (56.5) 37 (43.5)
Yes 131 (69.3) 58 (30.7) 99 (55.6) 79 (44.4)
Literate: able to read whole sentence?
No 44 (57.9) 32 (42.1) 32 (48.5) 34 (51.5)
Yes 145 (72.9) 54 (27.1) 116 (58.6) 82 (41.4)
Tobacco use, prior 30 days at baseline
No 170 (70.5) 71 (29.5) 129 (55.8) 102 (44.2)
Yes 19 (55.9) 15 (44.1) 19 (57.6) 14 (42.4)
Health status
Good/fair/poor/very poor 98 (71.0) 40 (29.0) 66 (55.0) 54 (45.0)
Excellent/very good 91 (66.4) 46 (33.6) 82 (56.9) 62 (43.1)
Social desirability
Low/moderate 89 (64.0) 50 (36.0) 67 (50.8) 65 (49.2)
High 100 (73.5) 36 (26.5) 81 (61.4) 51 (38.6)
Years since HIV diagnosis at baseline (median [IQR]) 8 [5–12] 7 [4–10] 8 [5–12] 7 [4–10]
*

Alcohol use: None: no self-report and PEth < 8; Moderate: any self-report but AUDIT-C negative, and/or 8 ng/mL <= PEth < 50 ng/mL; Unhealthy: AUDIT-C positive and/or PEth >= 50 ng/mL

α

Grade 2 or higher symptoms or liver enzyme elevations (LEEs) ≥2x upper limit of normal, in the prior 3 month